請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55291
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 丁詩同 | |
dc.contributor.author | Yuan-Yu Lin | en |
dc.contributor.author | 林原佑 | zh_TW |
dc.date.accessioned | 2021-06-16T03:55:07Z | - |
dc.date.available | 2020-02-04 | |
dc.date.copyright | 2015-02-04 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-12-23 | |
dc.identifier.citation | Advani, S., D. LaFrancis, E. Bogdanovic, P. Taxel, L.G. Raisz, and B.E. Kream. 1997. Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice. Bone 20:41-46.
Berg, A.H., T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947-953. Berner, H.S., S.P. Lyngstadaas, A. Spahr, M. Monjo, L. Thommesen, C.A. Drevon, U. Syversen, and J.E. Reseland. 2004. Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842-849. Berry, P.A., R.A. Maciewicz, F.M. Cicuttini, M.D. Jones, C.J. Hellawell, and A.E. Wluka. 2010. Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss. J. Rheumatol. 37:1252-1259. Bouxsein, M.L., S.K. Boyd, B.A. Christiansen, R.E. Guldberg, K.J. Jepsen, and R. Muller. 2010. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25:1468-1486. Bucay, N., I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, and W.S. Simonet. 1998. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260-1268. Carmen, G.Y., and S.M. Victor. 2006. Signalling mechanisms regulating lipolysis. Cell Signal. 18:401-408. Challa, T.D., Y. Rais, and E.M. Ornan. 2010. Effect of adiponectin on ATDC5 proliferation, differentiation and signaling pathways. Mol. Cell Endocrinol. 323:282-291. Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749. Chen, H.C., and R.V. Farese, Jr. 2002. Determination of adipocyte size by computer image analysis. J. Lipid Res. 43:986-989. Cheng, K.K., M.A. Iglesias, K.S. Lam, Y. Wang, G. Sweeney, W. Zhu, P.M. Vanhoutte, E.W. Kraegen, and A. Xu. 2009. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9:417-427. Chinetti, G., C. Zawadski, J.C. Fruchart, and B. Staels. 2004. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun. 314:151-158. Davies, B.S., A.P. Beigneux, L.G. Fong, and S.G. Young. 2012. New wrinkles in lipoprotein lipase biology. Curr. Opin. Lipidol. 23:35-42. Deepa, S.S., L. Zhou, J. Ryu, C. Wang, X. Mao, C. Li, N. Zhang, N. Musi, R.A. DeFronzo, F. Liu, and L.Q. Dong. 2011. APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway. Mol. Endocrinol. 25:1773-1785. Dempster, D.W., J.E. Compston, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, R.R. Recker, and A.M. Parfitt. 2013. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28:2-17. Dempster, D.W., F. Cosman, M. Parisien, V. Shen, and R. Lindsay. 1993. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14:690-709. Ding, S.T., B.H. Liu, and Y.H. Ko. 2004. Cloning and expression of porcine adiponectin and adiponectin receptor 1 and 2 genes in pigs. J. Anim. Sci. 82:3162-3174. Duque, G. 2008. Bone and fat connection in aging bone. Curr. Opin. Rheumatol. 20:429-434. Ealey, K.N., J. Kaludjerovic, M.C. Archer, and W.E. Ward. 2008. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp. Biol. Med. (Maywood). 233:1546-1553. Ferron, M., J. Wei, T. Yoshizawa, A. Del Fattore, R.A. DePinho, A. Teti, P. Ducy, and G. Karsenty. 2010. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296-308. Fulzele, K., R.C. Riddle, D.J. DiGirolamo, X. Cao, C. Wan, D. Chen, M.C. Faugere, S. Aja, M.A. Hussain, J.C. Bruning, and T.L. Clemens. 2010. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142:309-319. Gimble, J.M., S. Zvonic, Z.E. Floyd, M. Kassem, and M.E. Nuttall. 2006. Playing with bone and fat. J. Cell Biochem. 98:251-266. Gnecchi, M., Z. Zhang, A. Ni, and V.J. Dzau. 2008. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103:1204-1219. Hou, M., K.M. Yang, H. Zhang, W.Q. Zhu, F.J. Duan, H. Wang, Y.H. Song, Y.J. Wei, and S.S. Hu. 2007. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int. J. Cardiol. 115:220-228. Hsiao, F.S., C.C. Cheng, S.Y. Peng, H.Y. Huang, W.S. Lian, M.L. Jan, Y.T. Fang, E.C. Cheng, K.H. Lee, W.T. Cheng, S.P. Lin, and S.C. Wu. 2010. Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method. Cell Prolif. 43:235-248. Hu, E., P. Liang, and B.M. Spiegelman. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 271:10697-10703. Huang, C.Y., C.Y. Lee, M.Y. Chen, H.C. Tsai, H.C. Hsu, and C.H. Tang. 2010. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J. Cell Physiol. 224:475-483. Humphreys, B.D., and J.V. Bonventre. 2008. Mesenchymal stem cells in acute kidney injury. Annu. Rev. Med. 59:311-325. Hwang, Y.C., I.K. Jeong, K.J. Ahn, and H.Y. Chung. 2009. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab. Res. Rev. 25:768-772. Hwang, Y.C., I.K. Jeong, K.J. Ahn, and H.Y. Chung. 2012. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos. Int. 23:1337-1342. Ichida, F., R. Nishimura, K. Hata, T. Matsubara, F. Ikeda, K. Hisada, H. Yatani, X. Cao, T. Komori, A. Yamaguchi, and T. Yoneda. 2004. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 279:34015-34022. Jeyabalan, J., M. Shah, B. Viollet, and C. Chenu. 2012. AMP-activated protein kinase pathway and bone metabolism. J. Endocrinol. 212:277-290. Kadowaki, T., and T. Yamauchi. 2005. Adiponectin and adiponectin receptors. Endocr. Rev. 26:439-451. Kadowaki, T., T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116:1784-1792. Kanazawa, I., T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, and T. Sugimoto. 2009. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160:265-273. Kawaguchi, H., C.C. Pilbeam, and L.G. Raisz. 1994. Anabolic effects of 3,3',5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones. Endocrinology 135:971-976. Kim, E.K., S. Lim, J.M. Park, J.K. Seo, J.H. Kim, K.T. Kim, S.H. Ryu, and P.G. Suh. 2012. Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase. J. Cell Physiol. 227:1680-1687. Krishnan, V., H.U. Bryant, and O.A. Macdougald. 2006. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116:1202-1209. Kubota, N., Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, and T. Noda. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277:25863-25866. Kwan Tat, S., M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun. 2004. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15:49-60. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176. Lee, H.W., S.Y. Kim, A.Y. Kim, E.J. Lee, J.Y. Choi, and J.B. Kim. 2009. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27:2254-2262. Lee, N.K., H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, and G. Karsenty. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469. Lee, Y.S., Y.S. Kim, S.Y. Lee, G.H. Kim, B.J. Kim, S.H. Lee, K.U. Lee, G.S. Kim, S.W. Kim, and J.M. Koh. 2010. AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts. Bone 47:926-937. Lenchik, L., T.C. Register, F.C. Hsu, K. Lohman, B.J. Nicklas, B.I. Freedman, C.D. Langefeld, J.J. Carr, and D.W. Bowden. 2003. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646-651. Leroith, D., and D. Accili. 2008. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nat. Clin. Pract. Endocrinol. Metab. 4:164-172. Li, Y.C., M. Amling, A.E. Pirro, M. Priemel, J. Meuse, R. Baron, G. Delling, and M.B. Demay. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391-4396. Lin, G.L., and K.D. Hankenson. 2011. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J. Cell Biochem 112:3491-3501. Lin, Y.Y., C.Y. Chen, Y. Lin, Y.P. Chiu, C.C. Chen, B.H. Liu, H.J. Mersmann, S.C. Wu, and S.T. Ding. 2013. Modulation of glucose and lipid metabolism by porcine adiponectin receptor 1-transgenic mesenchymal stromal cells in diet-induced obese mice. Cytotherapy 15:971-978. Liu, B.H., Y.Y. Lin, Y.C. Wang, C.W. Huang, C.C. Chen, S.C. Wu, H.J. Mersmann, W.T. Cheng, and S.T. Ding. 2013. Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice. Exp. Anim. 62:347-360. Liu, L.F., W.J. Shen, Z.H. Zhang, L.J. Wang, and F.B. Kraemer. 2010. Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARgamma and adiponectin. J. Cell Physiol. 225:837-845. Liu, M., and F. Liu. 2014. Regulation of adiponectin multimerization, signaling and function. Best Pract. Res. Clin. Endocrinol. Metab. 28:25-31. Liu, M., L. Zhou, A. Xu, K.S. Lam, M.D. Wetzel, R. Xiang, J. Zhang, X. Xin, L.Q. Dong, and F. Liu. 2008. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc. Natl. Acad. Sci. U S A. 105:18302-18307. Luo, X.H., L.J. Guo, L.Q. Yuan, H. Xie, H.D. Zhou, X.P. Wu, and E.Y. Liao. 2005. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res. 309:99-109. Maeda, K., K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221:286-289. Mangi, A.A., N. Noiseux, D. Kong, H. He, M. Rezvani, J.S. Ingwall, and V.J. Dzau. 2003. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9:1195-1201. Manolagas, S.C., and R.L. Jilka. 1995. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332:305-311. Mao, X., C.K. Kikani, R.A. Riojas, P. Langlais, L. Wang, F.J. Ramos, Q. Fang, C.Y. Christ-Roberts, J.Y. Hong, R.Y. Kim, F. Liu, and L.Q. Dong. 2006. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8:516-523. Mitsui, Y., M. Gotoh, N. Fukushima, I. Shirachi, S. Otabe, X. Yuan, T. Hashinaga, N. Wada, A. Mitsui, T. Yoshida, S. Yoshida, K. Yamada, and K. Nagata. 2011. Hyperadiponectinemia enhances bone formation in mice. BMC Musculoskelet Disord. 12:18. Muruganandan, S., A.A. Roman, and C.J. Sinal. 2009. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol. Life Sci. 66:236-253. Nakano, Y., T. Tobe, N.H. Choi-Miura, T. Mazda, and M. Tomita. 1996. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120:803-812. Nakashima, T., M. Hayashi, and H. Takayanagi. 2012. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol. Metab. 23:582-590. Nauta, A.J., and W.E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. Okada-Iwabu, M., T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami, K. Matsuda, M. Yamaguchi, H. Tanabe, T. Kimura-Someya, M. Shirouzu, H. Ogata, K. Tokuyama, K. Ueki, T. Nagano, A. Tanaka, S. Yokoyama, and T. Kadowaki. 2013. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503:493-499. Okamoto, Y., S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby. 2006. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond). 110:267-278. Olefsky, J.M., and C.K. Glass. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72:219-246. Oshima, K., A. Nampei, M. Matsuda, M. Iwaki, A. Fukuhara, J. Hashimoto, H. Yoshikawa, and I. Shimomura. 2005. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331:520-526. Osler, M.E., and J.R. Zierath. 2008. Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 149:935-941. Owen, M. 1988. Marrow stromal stem cells. J. Cell Sci. Suppl. 10:63-76. Pacheco-Pantoja, E.L., V.J. Waring, P.J. Wilson, W.D. Fraser, and J.A. Gallagher. 2013. Adiponectin receptors are present in RANK-L-induced multinucleated osteoclast-like cells. J. Recept. Signal Transduct. Res. 33:291-297. Pacifici, R. 1998. Cytokines, estrogen, and postmenopausal osteoporosis--the second decade. Endocrinology 139:2659-2661. Panchal, S.K., and L. Brown. 2011. Rodent models for metabolic syndrome research. J. Biomed. Biotechnol. 2011:351982. Phinney, D.G., and D.J. Prockop. 2007. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 25:2896-2902. Raisz, L.G. 1999. Physiology and pathophysiology of bone remodeling. Clin. Chem. 45:1353-1358. Ramirez-Yanez, G.O., S. Hamlet, A. Jonarta, G.J. Seymour, and A.L. Symons. 2006. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study. Prostaglandins Leukot Essent Fatty Acids. 74:183-192. Rogers, N.H., J.W. Perfield, 2nd, K.J. Strissel, M.S. Obin, and A.S. Greenberg. 2009. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150:2161-2168. Rosen, C.J., and M.L. Bouxsein. 2006. Mechanisms of disease: is osteoporosis the obesity of bone? Nat. Clin. Pract. Rheumatol. 2:35-43. Rosen, C.J., and L.R. Donahue. 1998. Insulin-like growth factors and bone: the osteoporosis connection revisited. Proc. Soc. Exp. Biol. Med. 219:1-7. Ross, S.E., N. Hemati, K.A. Longo, C.N. Bennett, P.C. Lucas, R.L. Erickson, and O.A. MacDougald. 2000. Inhibition of adipogenesis by Wnt signaling. Science 289:950-953. Sadie-Van Gijsen, H., N.J. Crowther, F.S. Hough, and W.F. Ferris. 2013. The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol. Life Sci. 70:2331-2349. Saito, T., C.C. Jones, S. Huang, M.P. Czech, and P.F. Pilch. 2007. The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. J. Biol. Chem. 282:32280-32287. Scherer, P.E., S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270:26746-26749. Schmittgen, T.D., B.A. Zakrajsek, A.G. Mills, V. Gorn, M.J. Singer, and M.W. Reed. 2000. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285:194-204. Shah, M., B. Kola, A. Bataveljic, T.R. Arnett, B. Viollet, L. Saxon, M. Korbonits, and C. Chenu. 2010. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 47:309-319. Shinoda, Y., M. Yamaguchi, N. Ogata, T. Akune, N. Kubota, T. Yamauchi, Y. Terauchi, T. Kadowaki, Y. Takeuchi, S. Fukumoto, T. Ikeda, K. Hoshi, U.I. Chung, K. Nakamura, and H. Kawaguchi. 2006. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell Biochem. 99:196-208. Spranger, J., A. Kroke, M. Mohlig, M.M. Bergmann, M. Ristow, H. Boeing, and A.F. Pfeiffer. 2003. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 361:226-228. Takai, H., M. Kanematsu, K. Yano, E. Tsuda, K. Higashio, K. Ikeda, K. Watanabe, and Y. Yamada. 1998. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J. Biol. Chem. 273:27091-27096. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, and T. Taniguchi. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3:889-901. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science 289:1504-1508. Tomas, E., T.S. Tsao, A.K. Saha, H.E. Murrey, C. Zhang Cc, S.I. Itani, H.F. Lodish, and N.B. Ruderman. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U S A. 99:16309-16313. Tsuchida, A., T. Yamauchi, S. Takekawa, Y. Hada, Y. Ito, T. Maki, and T. Kadowaki. 2005. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 54:3358-3370. Tu, Q., J. Zhang, L.Q. Dong, E. Saunders, E. Luo, J. Tang, and J. Chen. 2011. Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J. Biol. Chem. 286:12542-12553. Urban, V.S., J. Kiss, J. Kovacs, E. Gocza, V. Vas, E. Monostori, and F. Uher. 2008. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26:244-253. Wang, C., X. Xin, R. Xiang, F.J. Ramos, M. Liu, H.J. Lee, H. Chen, X. Mao, C.K. Kikani, F. Liu, and L.Q. Dong. 2009. Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J. Biol. Chem. 284:31608-31615. Wang, F., P.X. Wang, X.L. Wu, S.Y. Dang, Y. Chen, Y.Y. Ni, L.H. Gao, S.Y. Lu, Y. Kuang, L. Huang, J. Fei, Z.G. Wang, and X.F. Pang. 2013. Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice. PLoS One. 8:e68497. Williams, G.A., Y. Wang, K.E. Callon, M. Watson, J.M. Lin, J.B. Lam, J.L. Costa, A. Orpe, N. Broom, D. Naot, I.R. Reid, and J. Cornish. 2009. In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603-3610. Wong, G.W., J. Wang, C. Hug, T.S. Tsao, and H.F. Lodish. 2004. A family of Acrp30/adiponectin structural and functional paralogs. Proc. Natl. Acad. Sci. U S A. 101:10302-10307. Wu, Y., Q. Tu, P. Valverde, J. Zhang, D. Murray, L.Q. Dong, J. Cheng, H. Jiang, M. Rios, E. Morgan, Z. Tang, and J. Chen. 2014. Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am J Physiol Endocrinol. Metab. 306:E1418-1430. Yamaguchi, N., T. Kukita, Y.J. Li, N. Kamio, S. Fukumoto, K. Nonaka, Y. Ninomiya, S. Hanazawa, and Y. Yamashita. 2008. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett. 582:451-456. Yamauchi, T., and T. Kadowaki. 2008. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond). 32 Suppl 7:S13-18. Yamauchi, T., and T. Kadowaki. 2013. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 17:185-196. Yamauchi, T., J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:1288-1295. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946. Yamauchi, T., Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, and T. Kadowaki. 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13:332-339. Yu, J.G., S. Javorschi, A.L. Hevener, Y.T. Kruszynska, R.A. Norman, M. Sinha, and J.M. Olefsky. 2002. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974. Zhang, D., G.C. Fan, X. Zhou, T. Zhao, Z. Pasha, M. Xu, Y. Zhu, M. Ashraf, and Y. Wang. 2008. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J. Mol. Cell Cardiol. 44:281-292. Zhou, L., S.S. Deepa, J.C. Etzler, J. Ryu, X. Mao, Q. Fang, D.D. Liu, J.M. Torres, W. Jia, J.D. Lechleiter, F. Liu, and L.Q. Dong. 2009. Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J. Biol. Chem. 284:22426-22435. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55291 | - |
dc.description.abstract | 脂肪組織除做為多餘能量的儲存場所外,亦可分泌多種脂肪細胞激素調節體內能量恆定及發炎反應等生理現象。脂締素為一與葡萄糖代謝及脂質代謝高度相關之脂肪細胞激素,其功能透過脂締素一型受體 (AdipoR1) 和脂締素二型受體 (AdipoR2) 媒介。本研究以全身型過度表現豬脂締素一型受體之小鼠為動物模式,在高脂及高蔗糖飼糧誘導的肥胖小鼠模式中發現過度表現脂締素一型受體能夠抑制胰島素不敏感、肥胖及脂肪肝現象;我們進一步地建立骨髓間葉幹細胞分離系統,並利用此轉基因小鼠的骨髓間葉幹細胞做為改善高脂高糖飼料引起的胰島素阻抗、葡萄糖耐受性及脂肪肝的治療策略,結果顯示過度表現脂締素一型受體之骨髓間葉幹細胞,確實可做為代謝性症候群的治療途徑。此外,代謝性症候群及老化所伴隨的骨質疏鬆症及骨質代謝性疾病也是近年研究所關注的議題,脂締素及其受體亦表現在骨髓、骨組織及成骨細胞中,而脂締素訊息在骨骼代謝及成骨細胞分化上扮演的角色尚未釐清,本論文以過度表現脂締素一型受體之小鼠為動物模式,發現過度表現脂締素一型受體可增加小鼠的骨密度、骨小樑容積及骨小樑數目,酵素結合免疫吸附法結果顯示過度表脂締素一型受體可增加 osteocalcin 及 osteoprotegrin 在血漿中濃度並減少蝕骨作用激素TRAP5b在血漿中的濃度。體外試驗結果顯示,利用慢病毒感染方法降低脂締素一型受體表現後,會減少骨髓間葉幹細胞及 MC3T3-E1 細胞在成骨細胞分化過程中osteocalcin, osteoprotegrin, alkaline phosphatase 及 msh homeobox 2 基因表現並降低礦化作用的生成。 除此之外,細胞訊息傳導路徑分析及即時定量PCR分析顯示脂締素一型受體可能透過 GSK-3 β 及 β-Catenin 訊息傳導路徑影響骨骼發育及成骨細胞的分化。綜合上述試驗結果顯示,脂締素一型受體在成骨細胞分化及骨骼形成過程中扮演重要角色,並具有潛力成為治療骨質疏鬆症或代謝性相關之骨生成疾病的治療方針。 | zh_TW |
dc.description.abstract | Adiponectin and its receptors have been demonstrated to play important roles in regulating glucose and lipid metabolism in mice. Obesity, type II diabetes and cardiovascular diseases are tightly correlated with down-regulation of adiponectin signaling. Our AdipoR1 transgenic mice with fluorescent proteins serve as a great model to investigate the involvement of adiponectin signaling in the biological processes. Mice overexpressing porcine adiponectin receptor 1 (pAdipoR1) fed with high fat/high sucrose diet for 24 weeks, exhibited no change in weight gain and demonstrated amelioration of insulin resistance. In this current study, we isolated the mesenchymal stem cells from wild-type (WT-MSC) and adiponectin receptor 1-transgenic mice (pR1-tMSC) and transplanted the cells into the diet-induced obese (DIO) mice, which exhibited diabetic and insulin insensitive. After once-a-week cell transplantation for 8 weeks, WT-MSC and pR1-tMSC treatments improved fatty acid oxidation and alleviate lipid accumulation in the liver, with pR1-tMSC further enhancing glucose metabolism in DIO mice. Our current study, for the first time, demonstrated therapeutic application of pR1-tMSC to improve diet-induced metabolic complications.
Metabolic syndrome and aging - associated osteoporosis and metabolic bone diseases is also an active field in recent years. Adiponectin and its receptors are expressed in bone marrow-derived osteoblasts. We used pAdipoR1 transgenic mice as a model to evaluate the role of AdipoR1 on bone physiology at different ages. pAdipoR1 transgenic mice had higher bone mineral density than wild-type mice in both genders at 56 weeks of age. The bone volume and trabecular number, measured by micro-computed tomography (μCT) were significantly greater in transgenic mice than those of wild-type female mice at both 8 and 56 weeks of age. ELISA analysis revealed that both serum osteocalcin and osteoprotegerin (OPG) were significantly increased in 8-week old pAdipoR1 transgenic mice of both genders. Furthermore, serum OPG was elevated at 32 and 56 weeks of age pAdipoR1 transgenic mice of both sex. Serum TRAP5b concentration was reduced in 8 and 56 weeks old male pAdipoR1 mice compared with wild-type male mice. Knock-down of AdipoR1 significantly decreased gene expression of osteocalcin, OPG, alkaline phosphatase and msh homeobox 2 and suppressed the mineralization in MC3T3-E1 cells and mesenchymal stem cells. In addition, pathscan analysis, and real-time PCR analysis suggested AdipoR1 regulates osteoblast differentiation through GSK-3 β and β-Catenin signaling. Consequently, the lack of AdipoR1 impaired osteoblast differentiation and bone formation. We concluded that AdipoR1 is a critical factor for the osteoblast differentiation and bone homeostasis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:55:07Z (GMT). No. of bitstreams: 1 ntu-103-F97626001-1.pdf: 2792940 bytes, checksum: b56e9bce4ef80fcdf6cf1d56317595b2 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | Contents
口試委員審定書 致謝............................................ ii 緒言............................................ iii 中文摘要........................................ v Abstract........................................vii List of Figures.................................xii List of Table...................................xiii Chapter 1 : Literature review 1.1 Adiponectin and adiponectin receptors...1 1.2 Bone remodeling.........................2 1.3 Functions of adiponectin and its receptors......5 1.3.1 Effects of ApN in systemic energy homeostasis.....5 1.3.2 Effect of ApN in bone metabolism...............10 1.4 Cross talk between energy homeostasis and bone metabolsim by adiponectin signaling ...................16 1.5 Conclusion.....................................18 Chapter 2 : Modulation of glucose and lipid metabolism by porcine adiponectin receptor 1-transgenic stromal stem cells in diet-induced obese mice 2.1 Abstract.......................................19 2.2 Introduction...................................20 2.3 Materials and Methods..........................23 2.3.1 Isolation, differentiation and characterization of murine MSC..........................................23 2.3.2 RNA extraction and real-time reverse transcription polymerase chain reaction................24 2.3.3 Western blot analysis.........................25 2.3.3 Histological analysis.........................27 2.3.4 In vivo experiment............................27 2.3.5 Glucose tolerance test........................28 2.3.6 Statistical analysis..........................28 2.4 Results.......................................29 2.4.1 Isolation and characterization of MSC.........29 2.4.2 Effects of MSC implantation on HFSD-induced body weight gain and blood glucose levels...................29 2.4.3 Effects of MSC transplantation on glucose metabolism – associated genes in the muscles of HFSD-fed mice...................................................30 2.4.4 MSC transplantation reduces hepatic lipid droplets and increase the expression of lipolytic genes in HFSD-fed mice.......................................31 1 2.4.5 Effects of pR1-tMSC transplantation on lipid metabolism – associated genes in the adipose tissue of HFSD-fed mice..........................................32 2.5 Discussion....................................32 Chapter 3: Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3β/β-Catenin signaling in mice 3.1 Abstract.......................................45 3.2 Introduction...................................46 3.3 Materials and Methods..........................50 3.3.1 Animal experiments............................50 3.3.2 Micro-computed tomography analysis............51 3.3.3 Enzyme-linked immunosorbent assay.............51 3.3.4 Isolation of bone marrow MSCs from mice and cell culture condictions....................................52 3.3.5 Knock-down of AdipoR1 by lentivirus infection and cell mineralization................................53 3.3.6 RNA extraction and real-time PCR..............54 3.3.7 Statistical analysis..........................56 3.4 Results........................................57 3.4.1 pAdipR1 transgenic mice have higher bone volume and trabecular number than wild-type mice..............57 3.4.2 Expression of bone turnover-related markers....58 3.4.3 Knock-down of AdipoR1 expression impaired osteoblast differentiation and mineralization in MSC and MC3T3-E1 cells.........................................58 3.4.4 AdipoR1 regulates osteoblast differentiation through GSK-3β and β-Catenin in MSC and MC3T3-E1 cells..................................................59 3.5 Discussion.....................................60 Chapter 4: Perspective.................................78 Reference..............................................82 Supplementary data.....................................93 | |
dc.language.iso | en | |
dc.title | 脂締素訊息傳導對葡萄糖和脂質代謝及骨質生成探討 | zh_TW |
dc.title | Modulation of glucose and lipid metabolism, and osteogenesis by adiponectin signaling | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 吳信志,陳靜宜 | |
dc.contributor.oralexamcommittee | 陳洵一,湯智昕,林峰輝 | |
dc.subject.keyword | 脂締素,脂締素一型受體,胰島素阻抗,代謝症候群,骨髓間葉幹細胞,成骨細胞分化與骨骼代謝, | zh_TW |
dc.subject.keyword | adiponectin,adiponectin receptor 1,insulin resistance,metabolisc syndrome,mesenchymal stem cell,osteoblast differentiation and bone metabolism, | en |
dc.relation.page | 95 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-12-24 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 2.73 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。